Sotera Health (NASDAQ:SHC) Shares Sold by Yousif Capital Management LLC

Yousif Capital Management LLC lessened its holdings in shares of Sotera Health (NASDAQ:SHC) by 3.0% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 55,422 shares of the company’s stock after selling 1,722 shares during the period. Yousif Capital Management LLC’s holdings in Sotera Health were worth $758,000 as of its most recent SEC filing.

Several other large investors have also recently bought and sold shares of the business. Blue Trust Inc. lifted its position in shares of Sotera Health by 164.3% during the 4th quarter. Blue Trust Inc. now owns 1,834 shares of the company’s stock valued at $25,000 after acquiring an additional 1,140 shares during the period. True Wealth Design LLC purchased a new position in Sotera Health in the 3rd quarter valued at approximately $32,000. GAMMA Investing LLC raised its holdings in Sotera Health by 37.5% during the fourth quarter. GAMMA Investing LLC now owns 4,109 shares of the company’s stock worth $56,000 after purchasing an additional 1,121 shares during the last quarter. Capital Performance Advisors LLP purchased a new stake in Sotera Health during the third quarter worth $91,000. Finally, Sanctuary Advisors LLC acquired a new stake in Sotera Health in the second quarter valued at $130,000. Hedge funds and other institutional investors own 91.03% of the company’s stock.

Sotera Health Stock Performance

Shares of SHC opened at $13.48 on Friday. Sotera Health has a 1 year low of $10.71 and a 1 year high of $17.44. The company’s 50 day simple moving average is $13.43 and its 200 day simple moving average is $14.56. The company has a market capitalization of $3.82 billion, a price-to-earnings ratio of 53.92 and a beta of 1.91. The company has a debt-to-equity ratio of 4.91, a quick ratio of 2.61 and a current ratio of 2.88.

Analyst Upgrades and Downgrades

Several research firms recently commented on SHC. Royal Bank of Canada reiterated an “outperform” rating and issued a $17.00 price objective on shares of Sotera Health in a research report on Thursday, November 21st. Citigroup upped their price target on shares of Sotera Health from $18.00 to $20.00 and gave the company a “buy” rating in a report on Wednesday, November 6th. Finally, The Goldman Sachs Group began coverage on Sotera Health in a research report on Friday, December 6th. They set a “neutral” rating and a $14.00 price objective for the company. Two investment analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and an average target price of $16.08.

About Sotera Health

Sotera Health Company engages in the provision of sterilization, lab testing, and advisory services in the United States and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. It provides mission-critical end-to-end sterilization services, including gamma and electron beam irradiation, and ethylene oxide processing, as well as designs, installs, and maintains gamma irradiation systems.